PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma
This study has been terminated.
(Manufacturer stopped drug development)
Sponsor:
David Rizzieri
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
David Rizzieri, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00511043
First received: August 1, 2007
Last updated: September 11, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | November 2012 |
| Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | September 7, 2012 |